Meitheal Pharmaceuticals (Meitheal) is pleased to announce the official launch of Dalbavancin for Injection 500 mg per vial, SDV:
- 71288-034-50 – Dalbavancin for Injection 500 mg per vial, SDV
ABOUT DALBAVANCIN FOR INJECTION 500 MG PER VIAL, SDV
Dalbavancin for Injection 500 mg per vial, SDV is a lipoglycopeptide antibacterial indicated for the treatment of adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms.
For full prescribing information, please click on the following link.
Learn more about who we are and what we do at: www.meithealpharma.com.
